/
INSP
$44.93-$0.79 (-1.73%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$1.3B
29M shares
52-week range
$38.91 – $147.03
6% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-153.40
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $50.6M | $82.0M | $115.4M | $233.4M | $407.9M | $624.8M | $802.8M | $912.0M |
| Cost of revenue | $10.1M | $13.6M | $17.6M | $33.3M | $66.1M | $96.6M | $123.0M | $133.2M |
| Gross profit | $40.5M | $68.4M | $97.8M | $200.1M | $341.7M | $528.2M | $679.8M | $778.8M |
| Gross margin | 80.1% | 83.4% | 84.7% | 85.7% | 83.8% | 84.5% | 84.7% | 85.4% |
| R&D | $7.4M | $12.8M | $26.1M | $37.4M | $68.6M | $116.5M | $114.1M | $103.2M |
| Operating income | −$20.4M | −$34.9M | −$56.2M | −$39.9M | −$47.6M | −$40.3M | $36.1M | $51.0M |
| EBITDA | −$18.1M | −$30.6M | −$54.1M | −$38.6M | −$40.7M | −$17.1M | $65.0M | $79.8M |
| Net income | −$21.8M | −$33.2M | −$57.2M | −$42.0M | −$44.9M | −$21.2M | $53.5M | $145.4M |
| Net margin | -43.1% | -40.5% | -49.6% | -18.0% | -11.0% | -3.4% | 6.7% | 15.9% |
| EPS (diluted) | -1.50 | -1.40 | -2.19 | -1.54 | -1.60 | -0.72 | 1.75 | 4.89 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $844M | $0.90 | $0.67–$1.54 | 8 |
| 2027 | $880M | $1.27 | $0.79–$1.98 | 9 |
| 2028 | $949M | $1.88 | $1.52–$2.34 | 6 |
| 2029 | $1.1B | $2.69 | $2.51–$3.06 | 4 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$164.11
Price
$44.93
Implied upside
+265%
Peer comparison
Inspire Medical Systems, Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
www.inspiresleep.com- Employees
- 1,333
- IPO / List date
- May 3, 2018
- HQ
- GOLDEN VALLEY, MN
Held by traders on TradeandTell
No one on the platform currently holds INSP.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 469,968 | $24.2M |
| Bridgewater Associatesas of 2026-03-31 | 173,533 | $9.0M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded INSP yet.
